Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Microcap & Penny Stocks : AMERICAN BIOMED, Minimally Invasive Technology (ABMI) -- Ignore unavailable to you. Want to Upgrade?

To: Jeffrey L. Henken who wrote (540)	4/23/1998 7:55:00 PM
From: Aishwarya	Read Replies (1) \| Respond to of 2887

Hi Jeff, Lots of crazies always seem to come to threads on down tick days and they seem to impact a lot subconciously and that includes me. one or two crazies are OK and fun to deal with anyways. Going back to consolidation in the Catheter and Stent industry i think this year and next year we will see a lot of buyouts etc, to increase the line of products. Its not my opinion but check this article right out of forbes: Murmur in Minneapolis JUST AS FORBES was going to press with a story warning investors about the hazards of companies that report sexy earnings performance but lousy sales growth (Mar. 9, 1998), one of our suspects, Medtronic, provided an object example. The Minneapolis-based firm, famous for cardiac pacemakers and other medical devices, announced a raft of layoffs and a $205 million pretax charge on fiscal third-quarter earnings. The cause? Slow sales growth in its vascular business, for one thing. Don't say we didn't warn you. This Wall Street darling had not reported a business-related charge against earnings since 1985, powering through three years of consecutive quarterly earnings growth of 15% or more. But its five-year annual sales growth of 16.5% lagged EPS growth of 27%, and it sported a P/E of 35. When news of the charge hit, the stock fell by 7%. The company says there's no crisis. Maybe not, but there is growing competition in coronary stents and angioplasty catheters. -STEPHAN HERRERA PS : This thread is indeed fortunate to have you posting and keeping everyone updated with the latest news and a flow of ideas and opinions . I know it is a lot of hard work behind every single post and really appreciate all your efforts. Regards, sri